James M Daly
CIK 1560782 · EVP, Chief Commercial Officer · last filed 2026-06-01
James M Daly is an EVP, Chief Commercial Officer who has filed 74 SEC Form 4 insider transactions across 7 companies since 2012. The most recent filing, for ACAD, was dated Jun 1, 2026. Across all open-market trades the lifetime net is −$41.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.13M
7
74
-$41.76M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACAD | Director | 12,148 | $21.09 | $256.2K | -$3.15M | 16 | 2026-06-01 |
| CYTK | Director | 3,239 | $70.15 | $227.2K | $0 | 4 | 2026-05-27 |
| MDGL | Director | 2,627 | $480.77 | $1.26M | -$13.59M | 9 | 2025-06-24 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Director | 20,503 | — | — | -$2.29M | 11 | 2023-08-15 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Director | 109,873 | $0.07 | $8.2K | $0 | 13 | 2023-01-05 |
| CHIMERIX INC (CMRX) Delisted | Director | — | $8.54 | — | $0 | 5 | 2019-06-24 |
| INCY | EVP, Chief Commercial Officer | 3,521 | $108.53 | $382.1K | -$22.72M | 16 | 2015-06-25 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | ACAD | Mixed | +8,107 | $0 | EDGAR |
| 2026-05-27 | CYTK | Grant (A) | +2,851 | $0 | EDGAR |
| 2026-04-15 | CYTK | Grant (A) | +191 | $12.5K | EDGAR |
| 2026-01-20 | CYTK | Grant (A) | +197 | $12.5K | EDGAR |
| 2025-11-12 | ACAD | Sell (S) | −30,000 | -$671.0K | EDGAR |
| 2025-08-20 | CYTK | Grant (A) | — | $0 | EDGAR |
| 2025-06-24 | MDGL | Grant (A) | +715 | $0 | EDGAR |
| 2025-06-02 | ACAD | Mixed | +9,387 | $0 | EDGAR |
| 2025-02-28 | MDGL | Mixed | — | -$4.09M | EDGAR |
| 2024-06-27 | MDGL | Grant (A) | +714 | $0 | EDGAR |